iifl-logo-icon 1

Mankind Pharma Ltd Share Price

2,145.8
(0.32%)
Jul 19, 2024|09:44:56 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open2,138.9
  • Day's High2,149.6
  • 52 Wk High2,490
  • Prev. Close2,138.85
  • Day's Low2,126.65
  • 52 Wk Low1,683.05
  • Turnover (lac)892.52
  • P/E47
  • Face Value1
  • Book Value239.8
  • EPS45.51
  • Mkt. Cap (Cr.)85,968.29
  • Div. Yield0
No Records Found

Mankind Pharma Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

2,138.9

Prev. Close

2,138.85

Turnover(Lac.)

892.52

Day's High

2,149.6

Day's Low

2,126.65

52 Week's High

2,490

52 Week's Low

1,683.05

Book Value

239.8

Face Value

1

Mkt Cap (₹ Cr.)

85,968.29

P/E

47

EPS

45.51

Divi. Yield

0

Mankind Pharma Ltd Corporate Action

24 Aug 2023

12:00 AM

AGM

Announcement Date: 24 Aug, 2023

arrow

8 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Mankind Pharma Ltd NEWS AND UPDATE

Mankind Pharma inks pact with Takeda to market Vonoprazan
18 Jul 2024|10:48 AM

The Delhi-based startup has signed in-licensing arrangements with Novartis for the heart failure treatment Neptaz.

Read More
₹771 Crore Block Deal Shakes Up Mankind Pharma Stock
10 Jul 2024|10:14 AM

Mankind Pharma's stock increased by more than 4% after the block deal. Mankind Pharma's shares were trading at ₹2,169 on the NSE at 09.23 am.

Read More
Top 10 stocks for today – 10th July 2024
10 Jul 2024|10:26 AM

Here are some of the stocks that may see significant price movement today: ONGC, Wipro, Reliance, RVNL, Mahindra & Mahindra, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd SHAREHOLDING SNAPSHOT

20 Jul, 2024|11:34 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 74.87%

Foreign: 0.00%

Indian: 74.87%

Non-Promoter- 21.52%

Institutions: 21.52%

Non-Institutions: 3.60%

Custodian: 0.00%

Share Price

Mankind Pharma Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

40.06

40.06

40.06

40.06

Preference Capital

0

0

0

0

Reserves

7,743.85

6,500.39

4,694.21

3,611.39

Net Worth

7,783.91

6,540.45

4,734.27

3,651.45

Minority Interest

View Balance Sheet
Loading...

No Record found

View Profit & Loss
Loading...

No Record found

View Cash Flow
Loading...

No Record found

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

10,334.77

8,749.43

7,781.56

6,214.43

5,865.23

Excise Duty

0

0

0

0

0

Net Sales

10,334.77

8,749.43

7,781.56

6,214.43

5,865.23

Other Operating Income

0

0

0

0

0

Other Income

296.07

140.99

210.48

182.63

121.96

Mankind Pharma Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,594.25

125.293,82,370.02867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,584.8

77.221,21,645.675310.652,259507.93

Cipla Ltd

CIPLA

1,506.65

32.741,21,616.251,038.40.563,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,185.65

34.71,19,268.911,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,667.5

25.951,11,193.661,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Mankind Pharma Ltd

Management

Register Office

Registrar Office

Chairman & Wholetime Director

RAMESH CHAND JUNEJA

Vice Chairman & M.D.

RAJEEV JUNEJA

Whole Time Director & CEO

SHEETAL ARORA

Independent Director

TILOKCHAND PUNAMCHAND OSTWAL

Company Sec. & Compli. Officer

Pradeep Chugh

Independent Director

Bharat Anand

Whole-time Director

SATISH KUMAR SHARMA

Independent Director

Vivek Kalra

Independent Director

Vijaya Sampath

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Mankind Pharma Ltd. was incorporated on July 3, 1991, as a Private Limited Company with the name Mankind Pharma Private Limited, by the Registrar of Companies, Delhi and Haryana, at New Delhi. Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to Mankind Pharma Limited and the RoC issued a fresh Certificate of Incorporation on April 13, 2006.The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products. It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory. In 2004, the Company entered the chronic pharmaceutical segment with the launch of Amlokind tablets and Glimestar tablets amongst others. It set up their first manufacturing facility at Paonta Sahib, in Himachal Pradesh during year 2005. It entered the ophthalmic pharmaceutical segment with the launching of Lubistar Eye Drops and Tobastar Eye Drops. In 2007, the Company entered the consumer healthcare segment with the launch of Manforce brand and have since established several differentiated brands in condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineralsupplements and anti-acne preparations categories. It entered into the business of animal heal
Read More

Company FAQs

What is the Mankind Pharma Ltd share price today?

Down Arrow

The Mankind Pharma Ltd shares price on N/A is Rs.₹2144.25 today.

What is the Market Cap of Mankind Pharma Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mankind Pharma Ltd is ₹85906.19 Cr. as of 19 Jul ‘24

What is the PE and PB ratio of Mankind Pharma Ltd?

Down Arrow

The PE and PB ratios of Mankind Pharma Ltd is 47 and 8.90 as of 19 Jul ‘24

What is the 52 Week High and Low of Mankind Pharma Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Mankind Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Mankind Pharma Ltd is ₹1680.5 and ₹2488.65 as of 19 Jul ‘24

What is the CAGR of Mankind Pharma Ltd?

Down Arrow

Mankind Pharma Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 15.98%, 6 Month at -0.17%, 3 Month at -10.78% and 1 Month at -4.75%.

What is the shareholding pattern of Mankind Pharma Ltd?

Down Arrow

The shareholding pattern of Mankind Pharma Ltd is as follows:
Promoters - 74.87 %
Institutions - 21.52 %
Public - 3.61 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.